PurpleLab key facts
- Operator of a healthcare data and analytics platform intended to simplify and enhance the lifecycle of discoveries from clinical and claims data.
- It has raised $64.8M; the latest was Mezzanine ($21.8M) in Sep 2025.
- Notable investors include Edison Partners, M7 Ace Neo, Nullam Dapidus, Primus Capital.
- Status: Privately Held (backing).
Who backs PurpleLab
4- ·Watch PurpleLab: the Monday email on marks, rounds and moves
PurpleLab funding rounds
No funding rounds for PurpleLab are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
PurpleLab investors
4 investors are on record for PurpleLab, including Edison Partners, M7 Ace Neo, Nullam Dapidus and Primus Capital.
About PurpleLab
Operator of a healthcare data and analytics platform intended to simplify and enhance the lifecycle of discoveries from clinical and claims data. The company's platform features on-demand access to customizable queries and reports templates to profile and rank providers based on their quantitative performance metrics and provides a marketplace for patients, employers, and insurance providers to search for healthcare professionals according to the required profile, enabling healthcare providers and life science organizations to model and measure episodes of care.
- Sector
- Healthcare
- HQ
- Wayne, PA, United States
- Founded
- 2015
- Employees
- 115
- Website
- purplelab.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
PurpleLab doesn't have a valuation on record yet — one is published once a priced round, a reported valuation, fund marks, or secondary prints surface in our sources. The rest of the record below builds toward it.